Efficacy and Safety of Weifuchun Tablet in Reversing Gastric Intestinal Metaplasia — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Efficacy and Safety of Weifuchun Tablet in Reversing Gastric Intestinal Metaplasia — Stella

Home/Gastric Intestinal Metaplasia/

View on ClinicalTrials.gov

Recruiting

Back to Gastric Intestinal Metaplasia trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

China

Xijing hospital, Xi'an

Key details

Phase

Post-approval study

Sponsor

Yongquan Shi

Enrollment target

~400 participants

Started

February 2025

Primary completion

October 2026

Age range

18 Years – 75 Years

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.